This process is driven by increased tumor hypoxia that manifests in stabilization of HIF-1α and HIF-1β heterodimer (hypoxia-inducible factor 1) and upregulation of SDF-1 (stromal cell-derived factor 1 or CXCL12). Here, CXCL12 is linked to neoplasm.